Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

TRDA Entrada Therapeutics PE ratio, current and historical analysis

As at Jun 5, 2025, the TRDA stock has a PE ratio of 10.02. This is based on the current EPS of $0.81 and the stock price of $8.12 per share. An increase of 14% has been recorded in the PE ratio compared to the average of 8.8 of the past four quarters.

TRDA PE ratio history

How has TRDA's PE ratio performed in the past

The mean historical PE ratio of Entrada Therapeutics over the last three years is 8.44. The current 10.02 price-to-earnings ratio is 19% more than the historical average. In the past three years, TRDA's PE ratio reached its highest point in the Mar 2024 quarter at 20.24, with a price of $14.17 and an EPS of $0.7. The Sep 2022 quarter saw the lowest point at 1.14, with a price of $15.76 and an EPS of $13.79.

Today
10.49
Average
8.44
Median
9.57
Minimum
1.14
Maximum
20.24

Entrada Therapeutics PE ratio by year

Year PE ratio PE change Price EPS
2024 9.82 N/A $17.29 $1.76
2023 N/A N/A $15.09 -$0.2
2022 N/A N/A $13.52 -$3.02
2021 N/A N/A $17.12 -$8.16
2020 N/A N/A N/A -$24
2019 N/A N/A N/A -$0.76

Entrada Therapeutics PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2025 11.16 13.65% $9.04 $0.81
Dec 2024 9.82 2.61% $17.29 $1.76
Sep 2024 9.57 107.59% $15.98 $1.67
Jun 2024 4.61 -77.22% $14.25 $3.09
Mar 2024 20.24 N/A $14.17 $0.7
Dec 2023 N/A N/A $15.09 -$0.2
Sep 2023 N/A N/A $15.8 -$0.7
Jun 2023 N/A N/A $15.14 -$2.57
Mar 2023 N/A N/A $14.5 -$2.53
Dec 2022 N/A N/A $13.52 -$3.02
Sep 2022 1.14 -54.94% $15.76 $13.79
Jun 2022 2.53 N/A $12.18 $4.81
Mar 2022 N/A N/A $9.39 -$2.01
Dec 2021 N/A N/A $17.12 -$8.16
Sep 2021 N/A N/A N/A -$31.46

TRDA Price vs fair value

How does TRDA's price compare to its estimated fair value based on its growth

TRDA average PE ratio chart

What is the average PE ratio of TRDA for the past years

The current PE ratio of TRDA is above its 3-year historical average.

3-year avg
8.44
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

TRDA PE vs peers

What is TRDA's PE ratio compared to its peers

TRDA's PE ratio is below its peer stocks AMGN and GILD. Entrada Therapeutics is presently trading at a lower PE ratio (10.02) than its peer group average of 18.38.

Stock name PE ratio Market cap
TRDA Entrada Therapeutics Inc 10.49 $322.6M
REGN Regeneron Pharmaceuticals Inc 11.9 $53.65B
BIIB Biogen Inc 13.07 $19.46B
GILD Gilead Sciences Inc 23.32 $138.4B
AMGN Amgen Inc 26.42 $156.97B
VRTX Vertex Pharmaceuticals Inc N/A $114.95B
NTLA Intellia Therapeutics Inc N/A $837.99M
MRNA Moderna Inc N/A $10.36B
CRSP CRISPR Therapeutics AG N/A $3.54B
EDIT Editas Medicine Inc N/A $160.73M

Frequently asked questions

What is Entrada Therapeutics's PE ratio?

TRDA stock has a price to earnings ratio of 10.02 as of Jun 5, 2025.

What is the 3-year average PE ratio for Entrada Therapeutics (TRDA)?

As an average over the last 3 years, TRDA stock has a PE ratio of 8.44.

What is the highest PE ratio for TRDA?

In the last three years, the Mar 2024 quarter recorded the highest quarterly PE ratio at 20.24.

How does the current PE ratio for TRDA compare to its historical average?

TRDA's current price to earnings ratio is 19% above its 3-year historical average.

How is TRDA's PE ratio calculated (Entrada Therapeutics PE ratio formula)?

You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jun 5, 2025), Entrada Therapeutics's stock price is $8.12. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.81. Therefore, Entrada Therapeutics's price to earnings ratio for today is 10.02. PE RATIO(10.02) = STOCK PRICE($8.12) / TTM EPS($0.81)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.